Erratum: Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate (Cancer (2006) 107,7, (1634-1641))

D. Meirow; J. Rabinovici; D. Katz; R. Or; D. Ben-Yehuda; Yoel Shufaro

doi:10.1002/cncr.22925

Erratum: Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate (Cancer (2006) 107,7, (1634-1641))

D. Meirow
, J. Rabinovici
, D. Katz
, R. Or
, D. Ben-Yehuda
, Yoel Shufaro

Institute for Medical Research Israel-Canada (IMRIC)

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	936
Number of pages	1
Journal	Cancer
Volume	110
Issue number	4
DOIs	https://doi.org/10.1002/cncr.22925
State	Published - 15 Aug 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/cncr.22925

Cite this

@article{d6955b07eb1e473381da672f5e21be36,

title = "Erratum: Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate (Cancer (2006) 107,7, (1634-1641))",

author = "D. Meirow and J. Rabinovici and D. Katz and R. Or and D. Ben-Yehuda and Yoel Shufaro",

year = "2007",

month = aug,

day = "15",

doi = "10.1002/cncr.22925",

language = "אנגלית",

volume = "110",

pages = "936",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

Meirow, D, Rabinovici, J, Katz, D, Or, R, Ben-Yehuda, D & Shufaro, Y 2007, 'Erratum: Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate (Cancer (2006) 107,7, (1634-1641))', Cancer, vol. 110, no. 4, pp. 936. https://doi.org/10.1002/cncr.22925

Erratum: Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate (Cancer (2006) 107,7, (1634-1641)). / Meirow, D.; Rabinovici, J.; Katz, D. et al.
In: Cancer, Vol. 110, No. 4, 15.08.2007, p. 936.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate (Cancer (2006) 107,7, (1634-1641))

AU - Meirow, D.

AU - Rabinovici, J.

AU - Katz, D.

AU - Or, R.

AU - Ben-Yehuda, D.

AU - Shufaro, Yoel

PY - 2007/8/15

Y1 - 2007/8/15

UR - https://www.scopus.com/pages/publications/34547865001

U2 - 10.1002/cncr.22925

DO - 10.1002/cncr.22925

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

AN - SCOPUS:34547865001

SN - 0008-543X

VL - 110

SP - 936

JO - Cancer

JF - Cancer

IS - 4

ER -

Erratum: Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate (Cancer (2006) 107,7, (1634-1641))

UN SDGs

Access to Document

Other files and links

Cite this